|
JPS4927290B1
(https=)
|
1969-08-05 |
1974-07-16 |
|
|
|
US4071618A
(en)
|
1974-09-03 |
1978-01-31 |
Research Foundation For Microbial Diseases Of Osaka University |
Process for preparing virus disease live vaccines
|
|
JPS57136528A
(en)
|
1981-02-09 |
1982-08-23 |
Hayashibara Biochem Lab Inc |
Preparation of viral vaccine
|
|
NZ219515A
(en)
|
1987-02-10 |
1989-09-27 |
Wellcome Found |
Fusion proteins comprising influenza virus ha and a nonnatural antigenic epitope
|
|
US5854037A
(en)
|
1989-08-28 |
1998-12-29 |
The Mount Sinai School Of Medicine Of The City University Of New York |
Recombinant negative strand RNA virus expression systems and vaccines
|
|
US6001634A
(en)
|
1989-08-28 |
1999-12-14 |
Palese; Peter |
Recombinant negative strand RNA viruses
|
|
US5840520A
(en)
|
1989-08-28 |
1998-11-24 |
Aviron |
Recombinant negative strand RNA virus expression systems
|
|
US5786199A
(en)
|
1989-08-28 |
1998-07-28 |
The Mount Sinai School Of Medicine Of The City University Of New York |
Recombinant negative strand RNA virus expression systems and vaccines
|
|
US5166057A
(en)
|
1989-08-28 |
1992-11-24 |
The Mount Sinai School Of Medicine Of The City University Of New York |
Recombinant negative strand rna virus expression-systems
|
|
US5919676A
(en)
|
1993-06-24 |
1999-07-06 |
Advec, Inc. |
Adenoviral vector system comprising Cre-loxP recombination
|
|
JP3484215B2
(ja)
|
1994-01-27 |
2004-01-06 |
花王株式会社 |
チャイニーズハムスター卵巣細胞変異株
|
|
US5750394A
(en)
|
1994-05-20 |
1998-05-12 |
The Mount Sinai Medical Center |
Identification and use of antiviral compounds that inhibit interaction of host cell proteins and viral proteins required for viral replication
|
|
CA2149197A1
(en)
|
1994-06-17 |
1995-12-18 |
Irene Popiel |
Production of an efficacious toxoplasma gondii bradyzoite vaccine in tissue culture
|
|
ATE257175T1
(de)
|
1994-07-18 |
2004-01-15 |
Conzelmann Karl Klaus Prof Dr |
Rekombinantes infektiöses nicht-in-segmente- geteiltes, negativ-strange-rns-virus
|
|
EP0700991A1
(en)
|
1994-09-12 |
1996-03-13 |
Bayer Corporation |
Commercial scale concentrated preharvest tissue culture produced live T. Gondii bradyzoite and products and processes
|
|
US5789229A
(en)
|
1994-09-30 |
1998-08-04 |
Uab Research Foundation |
Stranded RNA virus particles
|
|
EP0704533A1
(en)
|
1994-09-30 |
1996-04-03 |
Bayer Ag |
An attenuated vaccination virus, a method to make the virus and a pharmaceutical compositions comprising the virus
|
|
WO1996010631A1
(en)
|
1994-09-30 |
1996-04-11 |
St. Jude Children's Research Hospital |
Nucleic acid encoding mutant matrix proteins useful for attenuation or enhancement of influenza a virus
|
|
US5716821A
(en)
|
1994-09-30 |
1998-02-10 |
Uab Research Foundation |
Prevention and treatment of respiratory tract disease
|
|
US6843996B1
(en)
|
1995-06-05 |
2005-01-18 |
Medimmune Vaccines, Inc. |
Immunogenic composition comprising an influenza virus with a temperature sensitive PB2 mutation
|
|
ATE181112T1
(de)
|
1995-08-09 |
1999-06-15 |
Schweiz Serum & Impfinst |
Dem genom von minussträngigen rna-viren entsprechende cdna und verfahren zur herstellung von infektiösen minussträngigen rna-viren
|
|
US6037348A
(en)
|
1996-02-09 |
2000-03-14 |
Eli Lilly And Company |
Inhibition of viral replication
|
|
DE19612967A1
(de)
|
1996-04-01 |
1997-10-02 |
Behringwerke Ag |
Verfahren zur Vermehrung von Influenzaviren in Zellkultur, sowie die durch das Verfahren erhältlichen Influenzaviren
|
|
DE19612966B4
(de)
|
1996-04-01 |
2009-12-10 |
Novartis Vaccines And Diagnostics Gmbh & Co. Kg |
MDCK-Zellen und Verfahren zur Vermehrung von Influenzaviren
|
|
US5994526A
(en)
|
1996-06-21 |
1999-11-30 |
Plant Genetic Systems |
Gene expression in plants
|
|
WO1998002530A1
(en)
|
1996-07-15 |
1998-01-22 |
The Government Of The United States Of America, As Represented By The Department Of Health And Human Services |
Production of attenuated respiratory syncytial virus vaccines from cloned nucleotide sequences
|
|
US6271011B1
(en)
|
1996-10-15 |
2001-08-07 |
The University Of Georgia Research Foundation, Inc. |
Pasteurella neuraminidase coding sequences and diagnostic methods
|
|
TW570803B
(en)
|
1997-04-09 |
2004-01-11 |
Duphar Int Res |
Influenza vaccine
|
|
AU7471098A
(en)
|
1997-04-30 |
1998-11-24 |
Mount Sinai School Of Medicine Of The City University Of New York, The |
Recombinant influenza viruses expressing tumor-associated antigens as antitum or agents
|
|
BR9809456B1
(pt)
|
1997-05-23 |
2011-06-28 |
|
molécula isolada de polinucleotìdeo, composição de célula ou isenta de célula, partìcula de piv infeciosa, atenuada e imunogênica, e, composição imunogênica.
|
|
CA2297786C
(en)
|
1997-08-05 |
2011-06-14 |
Vlaams Interuniversitair Instituut Voor Biotechnologie |
New immunoprotective influenza antigen and its use in vaccination
|
|
US6169175B1
(en)
|
1997-08-06 |
2001-01-02 |
Centers For Disease Control And Prevention |
Preparation and use of recombinant influenza A virus M2 construct vaccines
|
|
US20020010143A1
(en)
|
1997-09-26 |
2002-01-24 |
Miguel S. Barbosa |
Compositions and methods for the treatment of human cytomegalovirus infection
|
|
KR100281676B1
(ko)
|
1997-11-29 |
2001-04-02 |
신동권 |
신규한독감생백신바이러스
|
|
US6146642A
(en)
|
1998-09-14 |
2000-11-14 |
Mount Sinai School Of Medicine, Of The City University Of New York |
Recombinant new castle disease virus RNA expression systems and vaccines
|
|
US6544785B1
(en)
|
1998-09-14 |
2003-04-08 |
Mount Sinai School Of Medicine Of New York University |
Helper-free rescue of recombinant negative strand RNA viruses
|
|
US6270958B1
(en)
|
1998-10-29 |
2001-08-07 |
Washington University |
Detection of negative-strand RNA viruses
|
|
JP4802366B2
(ja)
|
1999-02-22 |
2011-10-26 |
トランスジェン・ソシエテ・アノニム |
精製ウイルス調製物の取得方法
|
|
EP1035209A1
(en)
|
1999-03-06 |
2000-09-13 |
ARTEMIS Pharmaceuticals GmbH |
Stable recombinant influenza viruses free of helper viruses
|
|
DE122008000035I1
(de)
|
1999-04-06 |
2009-05-20 |
Wisconsin Alumni Res Found |
Rekombinante influenzaviren zur vakzinherstellung und gentherapie
|
|
US8715940B2
(en)
|
1999-04-06 |
2014-05-06 |
Wisconsin Alumni Research Foundation |
Method of making recombinant influenza virus
|
|
US6492169B1
(en)
|
1999-05-18 |
2002-12-10 |
Crucell Holland, B.V. |
Complementing cell lines
|
|
ES2278621T5
(es)
|
1999-07-14 |
2011-02-02 |
Mount Sinai School Of Medicine Of New York University |
Reconstrucción in vitro de virus arn segmentados de polaridad negativa.
|
|
CA2385823A1
(en)
|
1999-10-01 |
2001-04-12 |
Haifeng Chen |
Production of recombinant aav using adenovirus comprising aav rep/cap genes
|
|
US6686168B1
(en)
|
1999-11-04 |
2004-02-03 |
Zymogenetics, Inc. |
Cell surface display of proteins by recombinant host cells
|
|
US7192759B1
(en)
|
1999-11-26 |
2007-03-20 |
Crucell Holland B.V. |
Production of vaccines
|
|
WO2001049255A2
(en)
|
1999-12-30 |
2001-07-12 |
University Of Louisville Research Foundation, Inc. |
Methods and compositions for inhibiting adhesion by microorganisms
|
|
KR100797547B1
(ko)
|
2000-03-03 |
2008-01-24 |
자이단호진 가가쿠오요비겟세이료호겐쿠쇼 |
무혈청 배양 및 부유 배양에서 사용할 수 있는 세포 및상기 세포를 사용하여 백신용 바이러스를 제조하는 방법
|
|
JP4927290B2
(ja)
|
2000-04-14 |
2012-05-09 |
ウィスコンシン アルムニ リサーチ ファンデイション |
変異イオンチャンネルタンパク質を含んで成るウイルス
|
|
ES2319864T3
(es)
|
2000-04-28 |
2009-05-14 |
St. Jude Children's Research Hospital |
Sistema de transfeccion de adn para la generacion de virus infecciosos de arn de cadena negativa.
|
|
US6358733B1
(en)
|
2000-05-19 |
2002-03-19 |
Apolife, Inc. |
Expression of heterologous multi-domain proteins in yeast
|
|
US20040241139A1
(en)
|
2000-07-20 |
2004-12-02 |
Gerd Hobom |
Recombinant influenza viruses with bicistronic vRNAs coding for two genes in tandem arrangement
|
|
DE10038639A1
(de)
|
2000-07-28 |
2002-02-21 |
Schering Ag |
Nichtsteroidale Entzündungshemmer
|
|
EP1201760A1
(en)
|
2000-10-30 |
2002-05-02 |
ARTEMIS Pharmaceuticals GmbH |
Influenza virus vector for human dendritic cells
|
|
CA2435000C
(en)
|
2001-01-18 |
2014-03-25 |
Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw |
Oligomeric complexes of chimeric proteins with enhanced immunogenic potential
|
|
EP1233059A1
(en)
|
2001-02-09 |
2002-08-21 |
ARTEMIS Pharmaceuticals GmbH |
Influenza viruses with enhanced transcriptional and replicational capacities
|
|
US7176021B2
(en)
|
2001-02-23 |
2007-02-13 |
Wisconsin Alumni Research Foundation |
Mutant cells with altered sialic acid
|
|
DE10144906B4
(de)
|
2001-09-12 |
2013-11-28 |
Novartis Vaccines And Diagnostics Gmbh |
Verfahren zur großtechnischen Herstellung von Impfstoffen
|
|
US7682618B2
(en)
|
2001-11-07 |
2010-03-23 |
The United States Of America As Represented By The Secretary Of The Army |
Generation of virus-like particles and use as panfilovirus vaccine
|
|
EP1461424B1
(en)
|
2001-11-07 |
2013-01-16 |
U.S. Army Medical Research Institute of Infectious Diseases; Department of the Army |
Generation of virus-like particles and demonstration of lipid rafts as sites of filovirus entry and budding
|
|
US6951752B2
(en)
|
2001-12-10 |
2005-10-04 |
Bexter Healthcare S.A. |
Method for large scale production of virus antigen
|
|
US7211378B2
(en)
|
2002-01-31 |
2007-05-01 |
Wisconsin Alumni Research Foundation |
Filovirus vectors and noninfectious filovirus-based particles
|
|
KR101113432B1
(ko)
|
2002-02-13 |
2012-02-29 |
위스콘신 얼럼나이 리서어치 화운데이션 |
인플루엔자 바이러스 벡터의 패키징을 위한 신호
|
|
CN1997734A
(zh)
|
2002-02-13 |
2007-07-11 |
威斯康星旧生研究基金会 |
包装流感病毒载体的信号
|
|
AU2002239151A1
(en)
|
2002-03-08 |
2003-09-22 |
Crucell Holland B.V. |
Use of recombinant trypsin for vaccine production
|
|
FR2837497A1
(fr)
|
2002-03-22 |
2003-09-26 |
Univ Nantes |
Procede de production de vecteurs lentiviraux a haut titre
|
|
US7465456B2
(en)
|
2002-04-26 |
2008-12-16 |
Medimmune, Llc |
Multi plasmid system for the production of influenza virus
|
|
DK1499348T3
(en)
|
2002-04-26 |
2015-01-05 |
Medimmune Llc |
PROCEDURE FOR PREPARING INFECTIOUS INFLUENZA B-VIRA IN CELL CULTURE
|
|
WO2004042001A2
(en)
|
2002-05-17 |
2004-05-21 |
Emory University |
Virus-like particles, methods of preparation, and immonogenic compositions
|
|
US9045727B2
(en)
|
2002-05-17 |
2015-06-02 |
Emory University |
Virus-like particles, methods of preparation, and immunogenic compositions
|
|
EP2287288B1
(en)
|
2002-07-09 |
2012-11-07 |
Baxter International Inc. |
Animal protein free media for cultivation of cells
|
|
US6875433B2
(en)
|
2002-08-23 |
2005-04-05 |
The United States Of America As Represented By The Secretary Of The Army |
Monoclonal antibodies and complementarity-determining regions binding to Ebola glycoprotein
|
|
US20040242518A1
(en)
|
2002-09-28 |
2004-12-02 |
Massachusetts Institute Of Technology |
Influenza therapeutic
|
|
US20040142322A1
(en)
|
2002-10-07 |
2004-07-22 |
Schering Corporation |
Continuous non-radioactive polymerase assay
|
|
AU2004232992A1
(en)
|
2003-04-23 |
2004-11-04 |
Wisconsin Alumni Research Foundation |
Recombinant influenza viruses holding a mutation in a transmembrane protein gene
|
|
WO2005028658A2
(en)
|
2003-05-28 |
2005-03-31 |
Wisconsin Alumni Research Foundation |
Recombinant influenza vectors with a polii promoter and ribozymes
|
|
CA2525953C
(en)
|
2003-05-28 |
2023-10-10 |
Wisconsin Alumni Research Foundation |
High titer recombinant influenza viruses for vaccines and gene therapy
|
|
US7566458B2
(en)
|
2003-06-16 |
2009-07-28 |
Medimmune, Llc |
Influenza hemagglutinin and neuraminidase variants
|
|
US8592197B2
(en)
|
2003-07-11 |
2013-11-26 |
Novavax, Inc. |
Functional influenza virus-like particles (VLPs)
|
|
US20060240515A1
(en)
|
2003-07-21 |
2006-10-26 |
Dimitrov Dimiter S |
Soluble fragments of the SARS-CoV spike glycoprotein
|
|
US7037707B2
(en)
|
2003-09-04 |
2006-05-02 |
St. Jude Children's Research Hospital |
Method for generating influenza viruses and vaccines
|
|
US7279275B2
(en)
|
2003-11-03 |
2007-10-09 |
Washington University |
Methods and compositions for detection of segmented negative strand RNA viruses
|
|
CA2551489C
(en)
|
2003-12-23 |
2013-09-03 |
Gregory Duke |
Multi plasmid system for the production of influenza virus
|
|
JP2005245302A
(ja)
|
2004-03-04 |
2005-09-15 |
Kanazawa Univ Tlo Inc |
組換えインフルエンザウイルスおよびそれを用いたワクチン
|
|
US20060099609A1
(en)
|
2004-04-13 |
2006-05-11 |
Sina Bavari |
Activation of natural killer (NK) cells and methods of use
|
|
JP2007537760A
(ja)
|
2004-05-20 |
2007-12-27 |
アイディー バイオメディカル コーポレイション |
インフルエンザワクチンを製造するためのプロセス
|
|
ATE489965T1
(de)
|
2004-09-09 |
2010-12-15 |
Novartis Vaccines & Diagnostic |
Verminderung von potentiellen iatrogenen risiken in verbindung mit influenza impfstoffen
|
|
EP1812564A2
(en)
|
2004-11-11 |
2007-08-01 |
Solvay Pharmaceuticals B.V. |
Defective influenza virus particles
|
|
EA200701097A1
(ru)
|
2004-11-19 |
2007-10-26 |
Висконсин Эламни Рисёч Фаундэйшн |
Рекомбинантные векторы вируса гриппа с тандемными транскрипционными единицами
|
|
DK2368975T3
(en)
|
2004-12-23 |
2015-01-05 |
Medimmune Llc |
Non-tumorigenic MDCK cell line for the propagation of viruses
|
|
EP2295542B1
(en)
|
2004-12-24 |
2013-01-30 |
Abbott Biologicals B.V. |
Rescue of influenza virus
|
|
EP2471552B1
(en)
|
2005-03-08 |
2015-05-06 |
MedImmune, LLC |
Reassortant influenza viruses
|
|
AU2006236910B2
(en)
|
2005-04-11 |
2012-06-07 |
Purdue Research Foundation |
Vaccine against pandemic strains of influenza viruses
|
|
FR2887958B1
(fr)
|
2005-07-01 |
2007-10-12 |
Prospection Et D Inv S Techniq |
Dispositif de reglage de commande de vanne pour appareil de fixation a gaz et l'appareil comportant le dispositif
|
|
NL1030161C2
(nl)
|
2005-10-11 |
2007-04-12 |
Matthijs Dirk Meulenbelt |
Presentatie-inrichting.
|
|
EP1945778B1
(en)
|
2005-10-17 |
2012-12-26 |
MedImmune, LLC |
Methods of increasing influenza virus replication
|
|
PL2478916T3
(pl)
|
2006-01-27 |
2020-11-16 |
Seqirus UK Limited |
Szczepionki przeciw grypie zawierające hemaglutyninę i białka macierzy
|
|
CA2647985C
(en)
|
2006-03-31 |
2014-12-30 |
Warf-Wisconsin Alumni Research Foundation |
High titer recombinant influenza viruses for vaccines
|
|
AU2014202470B2
(en)
|
2006-03-31 |
2016-08-04 |
Wisconsin Alumni Research Foundation |
High titer recombinant influenza viruses for vaccines
|
|
AU2012204138B2
(en)
|
2006-03-31 |
2014-02-06 |
Wisconsin Alumni Research Foundation |
High titer recombinant influenza viruses for vaccines
|
|
US7883844B2
(en)
|
2006-05-11 |
2011-02-08 |
Juridical Foundation The Chemosero-Therapeutic Research Institute |
Method for propagating influenza virus
|
|
WO2007146057A2
(en)
|
2006-06-09 |
2007-12-21 |
Wisconsin Alumni Research Foundation |
Screening method for modulators of viral transcription or replication
|
|
US7507411B2
(en)
|
2006-06-23 |
2009-03-24 |
University Of Saskatchewan |
Attenuated influenza NS1 variants
|
|
WO2008133701A1
(en)
|
2006-07-21 |
2008-11-06 |
Medimmune, Llc. |
Methods and compositions for increasing replication capacity of an influenza virus
|
|
CN104140958A
(zh)
|
2006-08-09 |
2014-11-12 |
米迪缪尼有限公司 |
流感血凝素和神经氨酸酶变体
|
|
EP2615167A1
(en)
|
2006-09-15 |
2013-07-17 |
MedImmune, LLC |
Method for eliminating DNA contaminants from viral preparations
|
|
PT2121011E
(pt)
|
2006-12-06 |
2014-07-31 |
Novartis Ag |
Vacinas compreendendo um antigénio a partir de quatro estirpes do vírus da gripe
|
|
US8465960B2
(en)
|
2007-03-28 |
2013-06-18 |
Wisconsin Alumni Research Foundation |
Influenza B viruses with reduced sensitivity to neuraminidase inhibitors
|
|
DK2137511T3
(en)
*
|
2007-04-16 |
2019-03-11 |
Bae Systems Plc |
CORROSION SENSORS
|
|
WO2008147496A2
(en)
|
2007-05-04 |
2008-12-04 |
Warf - Wisconsin Alumni Research Foundation |
Neuraminidase-deficient live influenza vaccines
|
|
US8043856B2
(en)
|
2007-06-14 |
2011-10-25 |
Wisconsin Alumni Research Foundation |
Adenoviral vectors for influenza virus production
|
|
US9474798B2
(en)
|
2007-06-18 |
2016-10-25 |
Wisconsin Alumni Research Foundation |
Influenza M2 protein mutant viruses as live influenza attenuated vaccines
|
|
EP2674486A1
(en)
|
2007-06-18 |
2013-12-18 |
MedImmune, LLC |
Influenza B viruses having alterations in the hemaglutinin polypeptide
|
|
US8499329B2
(en)
|
2007-06-21 |
2013-07-30 |
Cisco Technology Inc. |
Power saving device
|
|
EP2048237A1
(en)
|
2007-10-05 |
2009-04-15 |
Avir Green Hills Biotechnology Research Development Trade Ag |
Replication deficient Influenza virus for the expression of heterologous sequences
|
|
KR20100045437A
(ko)
|
2007-06-27 |
2010-05-03 |
노파르티스 아게 |
첨가물이 적은 인플루엔자 백신
|
|
WO2009014919A2
(en)
|
2007-07-13 |
2009-01-29 |
Iowa State University Research Foundation, Inc. |
H2n3 influenza a viruses and methods of use
|
|
JP2011500036A
(ja)
|
2007-10-15 |
2011-01-06 |
ザ ユニバーシティー オブ クイーンズランド |
構築物系およびその使用
|
|
WO2009128867A2
(en)
|
2008-01-07 |
2009-10-22 |
Warf - Wisconsin Alumni Research Foundation |
Recombinant biologically contained filovirus
|
|
EP2296701A1
(en)
|
2008-06-11 |
2011-03-23 |
Flugen, Inc. |
Cell-based systems for producing influenza vaccines
|
|
RU2523587C2
(ru)
|
2008-07-11 |
2014-07-20 |
МЕДИММЬЮН, ЭлЭлСи |
Варианты гемагглютинина и нейрамидазы вируса гриппа
|
|
NO2324113T3
(https=)
|
2008-08-08 |
2018-07-28 |
|
|
|
WO2010053573A2
(en)
|
2008-11-07 |
2010-05-14 |
Yoshihiro Kawaoka |
Screen for inhibitors of filovirus and uses therefor
|
|
SI2454364T1
(sl)
|
2009-07-16 |
2014-08-29 |
Crucell Holland B.V. |
Izdelava polio virusa v visokih titrih za izdelavo cepiva
|
|
US9217157B2
(en)
|
2009-07-27 |
2015-12-22 |
Icahn School Of Medicine At Mount Sinai |
Recombinant influenza viruses and uses thereof
|
|
US8828406B2
(en)
|
2009-07-30 |
2014-09-09 |
Icahn School Of Medicine At Mount Sinai |
Influenza viruses and uses thereof
|
|
US8507247B2
(en)
|
2009-08-11 |
2013-08-13 |
Wisconsin Alumni Research Foundation |
Influenza A virus with attenuating mutations in NS2 protein
|
|
EP2493912B1
(en)
|
2009-10-26 |
2020-07-29 |
Wisconsin Alumni Research Foundation |
High titer recombinant influenza viruses with enhanced replication in vero cells
|
|
GB0919117D0
(en)
|
2009-10-30 |
2009-12-16 |
Glaxosmithkline Biolog Sa |
Process
|
|
KR101740019B1
(ko)
|
2009-11-10 |
2017-05-26 |
주식회사 팬택 |
무선통신시스템에서 시스템 정보 송수신 방법 및 그를 이용한 시스템 정보 송신장치와 수신장치
|
|
AP2012006321A0
(en)
|
2009-11-23 |
2012-06-30 |
Wrigley W M Jun Co |
Gum bases, chewing gums based thereupon, and methods for making the same.
|
|
WO2011087839A1
(en)
*
|
2009-12-22 |
2011-07-21 |
Baxter International Inc. |
Vaccine to influenza a virus
|
|
US10130697B2
(en)
|
2010-03-23 |
2018-11-20 |
Wisconsin Alumni Research Foundation (Warf) |
Vaccines comprising mutant attenuated influenza viruses
|
|
WO2011126370A1
(en)
|
2010-04-09 |
2011-10-13 |
Universiteit Utrecht Holding B.V. |
Recombinant multimeric influenza proteins
|
|
US9526777B2
(en)
|
2010-04-16 |
2016-12-27 |
The United States Of America As Represented By The Department Of Health And Human Services |
Methods for the induction of ebola virus-specific immune responses comprising administering a replication-defective chimpanzee adenovirus vector expressing the ebola virus glycoprotein
|
|
GB201011502D0
(en)
|
2010-07-08 |
2010-08-25 |
Glaxosmithkline Biolog Sa |
Novel process
|
|
US9534042B2
(en)
|
2010-09-03 |
2017-01-03 |
Fujita Health University |
Influenza virus-neutralizing antibody and screening method therefor
|
|
WO2012033236A1
(ko)
|
2010-09-06 |
2012-03-15 |
에스케이케미칼 주식회사 |
무혈청 배양 및 부유 배양에 적응된 ｍｄｃｋ 세포주 및 상기 세포를 사용하여 백신용 바이러스를 제조하는 방법
|
|
MY164376A
(en)
|
2010-10-07 |
2017-12-15 |
Univ Leuven Kath |
Phosphospecific antibodies recognizing tau
|
|
US20130243744A1
(en)
|
2011-01-06 |
2013-09-19 |
Michael J. Betenbaugh |
Method of production of recombinant glycoproteins with increased circulatory half-life in mammalian cells
|
|
KR102080061B1
(ko)
|
2011-06-24 |
2020-02-21 |
플루젠, 인코퍼레이티드 |
인플루엔자 바이러스 돌연변이체들 및 그들의 용도들
|
|
JP2014527799A
(ja)
|
2011-08-26 |
2014-10-23 |
ダブリュエーアールエフ−ウィスコンシン アラムナイ リサーチ ファウンデーション |
変異型ｐｂ２遺伝子セグメントを有する弱毒化生ワクチンとしてのインフルエンザウイルス
|
|
CN102304495A
(zh)
|
2011-09-08 |
2012-01-04 |
中国农业科学院上海兽医研究所 |
高效表达ha蛋白的重组流感病毒及其制备方法和应用
|
|
CN103608453B
(zh)
|
2012-03-02 |
2018-07-24 |
思齐乐 |
流感病毒重配
|
|
AU2013240248B2
(en)
|
2012-03-26 |
2018-12-20 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Delivery of packaged RNA to mammalian cells
|
|
CA2891508A1
(en)
*
|
2012-11-16 |
2014-05-22 |
Medimmune, Llc |
Swine influenza hemagglutinin and neuraminidase variants
|
|
WO2014150877A2
(en)
|
2013-03-15 |
2014-09-25 |
Ac Immune S.A. |
Anti-tau antibodies and methods of use
|
|
CN105722976A
(zh)
|
2013-06-06 |
2016-06-29 |
诺华股份有限公司 |
流感病毒重配
|
|
WO2015009743A1
(en)
|
2013-07-15 |
2015-01-22 |
Wisconsin Alumni Research Foundation |
High titer recombinant influenza viruses with enhanced replication in mdck or vero cells or eggs
|
|
KR20220013460A
(ko)
|
2014-03-04 |
2022-02-04 |
시그마-알드리치 컴퍼니., 엘엘씨 |
바이러스 내성 세포 및 이의 용도
|
|
WO2015142671A2
(en)
|
2014-03-17 |
2015-09-24 |
Flugen, Inc. |
Influenza virus vectors and uses therefor
|
|
US10053671B2
(en)
|
2014-06-20 |
2018-08-21 |
Wisconsin Alumni Research Foundation (Warf) |
Mutations that confer genetic stability to additional genes in influenza viruses
|
|
EP3188752A2
(en)
|
2014-09-03 |
2017-07-12 |
Bavarian Nordic A/S |
Recombinant modified vaccinia virus ankara (mva) filovirus vaccine
|
|
JP2017531642A
(ja)
|
2014-10-03 |
2017-10-26 |
マサチューセッツ インスティテュート オブ テクノロジー |
エボラ糖タンパク質に結合する抗体およびその使用
|
|
TWI710573B
(zh)
|
2015-01-26 |
2020-11-21 |
美商再生元醫藥公司 |
抗伊波拉病毒醣蛋白之人類抗體
|
|
US10429386B2
(en)
|
2015-03-10 |
2019-10-01 |
The Regents Of The University Of California |
Antibodies to the surface of Toxoplasma gondii oocysts and methods of use thereof
|
|
US10633422B2
(en)
|
2015-06-01 |
2020-04-28 |
Wisconsin Alumni Research Foundation (Warf) |
Influenza virus replication by inhibiting microRNA lec7C binding to influenza viral cRNA and mRNA
|
|
US11013795B2
(en)
|
2015-06-26 |
2021-05-25 |
Seqirus UK Limited |
Antigenically matched influenza vaccines
|
|
US9890363B2
(en)
|
2015-07-06 |
2018-02-13 |
Wisconsin Alumni Research Foundation (Warf) |
Influenza virus replication for vaccine development
|
|
US20170121391A1
(en)
|
2015-07-07 |
2017-05-04 |
Wisconsin Alumni Research Foundation (Warf) |
Potent glycoprotein antibody as a therapeutic against ebola virus
|
|
US10494613B2
(en)
|
2015-08-28 |
2019-12-03 |
Wisconsin Alumni Research Foundation (Warf) |
Generation of infectious influenza viruses from virus-like particles
|
|
CN105296356A
(zh)
|
2015-12-02 |
2016-02-03 |
河南农业大学 |
一种刚地弓形虫卵囊的制备、纯化及保存方法
|
|
US10063211B2
(en)
|
2016-02-03 |
2018-08-28 |
Qualcomm Incorporated |
Compact bypass and decoupling structure for millimeter-wave circuits
|
|
US11197925B2
(en)
|
2016-02-19 |
2021-12-14 |
Wisconsin Alumni Research Foundation (Warf) |
Influenza B virus replication for vaccine development
|
|
JP2018064493A
(ja)
|
2016-10-19 |
2018-04-26 |
京都府公立大学法人 |
Ｍｄｃｋ細胞を用いたインフルエンザウイルスの増殖方法
|
|
WO2019084310A1
(en)
|
2017-10-25 |
2019-05-02 |
Yoshihiro Kawaoka |
HAS RECOMBINANT INFLUENZA VIRUSES STABILIZED FOR EGG REPLICATION
|
|
WO2019241579A1
(en)
|
2018-06-13 |
2019-12-19 |
Wisconsin Alumni Research Foundation |
Toxoplasma gondii vaccine
|
|
US12343390B2
(en)
|
2018-08-07 |
2025-07-01 |
Wisconsin Alumni Research Foundation (Warf) |
Recombinant biologically contained filovirus vaccine
|
|
JP7655849B2
(ja)
|
2018-08-20 |
2025-04-02 |
ウィスコンシン アルムニ リサーチ ファンデイション |
ヘマグルチニン（ｈａ）タンパク質内の非ドミナントエピトープに対する免疫応答を誘起するためのベクター
|
|
WO2020061443A2
(en)
|
2018-09-21 |
2020-03-26 |
Board Of Regents Of The University Of Nebraska |
Methods of making and using universal centralized influenza vaccine genes
|
|
EP3914295A2
(en)
|
2019-01-23 |
2021-12-01 |
Yoshihiro Kawaoka |
Mutations that confer genetic stability to additional genes in influenza viruses
|
|
EP3921413A1
(en)
|
2019-02-08 |
2021-12-15 |
Wisconsin Alumni Research Foundation (WARF) |
Humanized cell line
|
|
CN114929269A
(zh)
|
2019-05-01 |
2022-08-19 |
威斯康星校友研究基金会(Warf) |
用于疫苗开发的改进的流感病毒复制
|
|
WO2020264141A1
(en)
|
2019-06-26 |
2020-12-30 |
Icahn School Of Medicine At Mount Sinai |
Influenza virus neuraminidase and uses thereof
|
|
US11807872B2
(en)
|
2019-08-27 |
2023-11-07 |
Wisconsin Alumni Research Foundation (Warf) |
Recombinant influenza viruses with stabilized HA for replication in eggs
|
|
JP2023511444A
(ja)
|
2020-01-24 |
2023-03-17 |
ウィスコンシン アルムニ リサーチ ファンデイション |
安定化されたｎａを有する組換えインフルエンザウイルス
|
|
US10953089B1
(en)
|
2020-01-27 |
2021-03-23 |
Novavax, Inc. |
Coronavirus vaccine formulations
|
|
WO2021195410A1
(en)
|
2020-03-25 |
2021-09-30 |
Wisconsin Alumni Research Foundation (Warf) |
Recombinant multivalent influenza viruses
|
|
WO2021242597A1
(en)
|
2020-05-23 |
2021-12-02 |
Wisconsin Alumni Research Foundation ("Warf") |
Ace2 expressing influenza virus
|
|
WO2022245888A1
(en)
|
2021-05-19 |
2022-11-24 |
Modernatx, Inc. |
Seasonal flu rna vaccines and methods of use
|
|
US20230321217A1
(en)
|
2021-09-28 |
2023-10-12 |
Yoshihiro Kawaoka |
Compositions comprising complexes displaying antigens and methods of using the compositions
|
|
WO2023125889A1
(en)
|
2021-12-31 |
2023-07-06 |
Suzhou Abogen Biosciences Co., Ltd. |
Quadrivalent mrna vaccines for influenza viruses
|
|
US20230346911A1
(en)
|
2022-02-23 |
2023-11-02 |
Wisconsin Alumni Research Foundation |
Broadly protective influenza b virus vaccines
|
|
US20250387467A1
(en)
|
2022-07-13 |
2025-12-25 |
Wisconsin Alumni Research Foundation |
Sars-cov-2 lacking the envelope protein as an attenuated vaccine virus against covid-19
|
|
US20240238403A1
(en)
|
2022-11-16 |
2024-07-18 |
Wisconsin Alumni Research Foundation |
Influenza virus replication for vaccine development
|
|
WO2024197167A1
(en)
|
2023-03-21 |
2024-09-26 |
Wisconsin Alumni Research Foundation |
A cold-adapted, live attenuated sars-cov-2 vaccine
|